(Q45258982)

English

Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib (English)

1 reference

Europe PubMed Central

11 December 2017

author name string

Mario Sánchez-Borges

1

1 reference

Europe PubMed Central

11 December 2017

Fernan Caballero-Fonseca

2

1 reference

Europe PubMed Central

11 December 2017

Arnaldo Capriles-Hulett

3

1 reference

Europe PubMed Central

11 December 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

11 December 2017

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

11 December 2017

94

1 reference

Europe PubMed Central

11 December 2017

1

1 reference

Europe PubMed Central

11 December 2017

34-38

1 reference

Europe PubMed Central

11 December 2017

Aspirin and allergic diseases: A review

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cutaneous reactions to aspirin and nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of selective cyclooxygenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

NSAID-induced urticaria and angioedema: a reappraisal of its clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorescence quenching analysis of the association and dissociation of a diarylheterocycle to cyclooxygenase-1 and cyclooxygenase-2: dynamic basis of cyclooxygenase-2 selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961282-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)61282-3

1 reference

Europe PubMed Central

11 December 2017

1 reference

Europe PubMed Central

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45258982&oldid=2071840635"